Healthcare
Getinge AB (publ)(GNGBF)
Live Price
Offline$20.05
+0.00% today
1Y Change
-5.02%
Window
Jun 25, 2025 โ Jun 24, 2026
- Market Cap
- $49.99B
- Revenue Growth
- +0.6%
- EPS Growth
- +37.6%
- Dividend Yield
- 2.6%
Coverage: 250 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Getinge AB (publ) (GNGBF) is a Healthcare stock with a market cap of $49.99B and listed on OTC. The stock last traded around $20.05 and down 5.0% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +0.6%, EPS growth of +37.6%, a dividend yield of 2.6%. What stands out right now is revenue +0.6%, EPS +37.6%, free cash flow -19.4% with operating margin 12.2% and ROIC 6.4%. The dividend matters to the case here, with a current yield around 2.6%. Valuation is more restrained than many high-expectation growth names at P/E 21.2 and price/sales 1.5. Stock Foundry combines GNGBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+0.6% vs +7.6% peer median
Operating Margin
Below sector median
+12.2% vs +19.4% peer median
P/E
Below sector median
21.2 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 21, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +0.6% and EPS at +37.6%, with operating margin around 12.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.6%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 21, 2026 | โ | +0.0% | +0.0% | -13.7% |
2026 Jan 27, 2026 | +9.0% | +0.0% | +0.0% | -6.1% |
2025 Oct 21, 2025 | -3.0% | +0.0% | +0.0% | +0.0% |
Benchmark Edge
GNGBF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
GNGBF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
GNGBF Max Drawdown
-18.99%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for GNGBF and SPY.
Company Overview
Getinge AB (publ)
Other OTC
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
- Leadership
- Mattias Perjos
- IPO Date
- Apr 6, 2011
- Employees
- 11.8k
- Street Address
- Lindholmspiren 7A
- Mailing
- Gothenburg, 417 56
- Region
- Gothenburg, SE
- Reporting Currency
- USD
- Investor Line
- 46 1 03 35 00 00
- Last Updated
- Apr 29, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 21.2
- EV/EBITDA
- 9.5
- Price/Sales
- 1.5
- Price/Book
- 1.6
Growth
- Revenue
- +0.6%
- EPS
- +37.6%
- Free Cash Flow
- -19.4%
Profitability
- Gross Margin
- 45.7%
- Operating Margin
- 12.2%
- Net Margin
- 6.9%
- ROE
- 8.0%
- ROIC
- 6.4%
Balance Sheet
- Debt/Equity
- 0.35
- Current Ratio
- 1.35
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.